Your shopping cart is currently empty

Wnt/β-catenin-IN-1 (compounds 17) is an inhibitor of the Wnt/β-catenin signaling pathway. It induces apoptosis in colon cancer cells and exhibits broad-spectrum anticancer activity, making it useful for research on various solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Wnt/β-catenin-IN-1 (compounds 17) is an inhibitor of the Wnt/β-catenin signaling pathway. It induces apoptosis in colon cancer cells and exhibits broad-spectrum anticancer activity, making it useful for research on various solid tumors. |
| In vitro | Wnt/β-catenin-IN-1 (compounds 17) exhibits broad-spectrum anticancer activity at 10 μM for 48 hours, achieving an average growth inhibition rate of 81.9% across 52 tested tumor cell lines. It shows low cytotoxicity towards normal human cell lines (CCD841, MRC5) and demonstrates selectivity for cancer cells. Moreover, Wnt/β-catenin-IN-1 induces dose-dependent cell cycle arrest, increasing the population of HCT116 colon cancer cells in the G2/M phase at concentrations of 0, 0.5, 1, and 2 μM over 24 or 48 hours. Additionally, at 0, 0.5, 1, and 2 μM for 24 hours, it dose-dependently reduces CDK8 levels in HCT colorectal cancer cells. |
| Formula | C26H25NO7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.